A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

NCT ID: NCT05085366

Last Updated: 2025-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

7454 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-26

Study Completion Date

2025-11-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety and reactogenicity of mRNA-1647 vaccine in all participants. The purpose of the Phase 3 extension substudy is to extend the observation period of the main study and to assess the longer-term immunogenicity, efficacy, and safety of the mRNA-1647 vaccine against primary CMV infection in healthy females who were CMV-seronegative at Baseline of the mRNA-1647-P301 main study (including participants who remain CMV-seronegative upon entry into the extension substudy and participants who seroconverted during the main study). The extension substudy will also evaluate the immune persistence and safety of mRNA-1647 in a subset of female participants who were CMV-seropositive at Baseline of the main study. No interventional vaccine will be administered in the extension substudy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cytomegalovirus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Observer-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mRNA-1647

Participants will receive mRNA-1647 vaccine by intramuscular (IM) injection on Day 1, Day 57, and Day 169.

Group Type EXPERIMENTAL

mRNA-1647

Intervention Type BIOLOGICAL

Lyophilized product that is reconstituted with 0.9% sodium chloride (normal saline)

Placebo

Participants will receive mRNA-1647 vaccine matching placebo by IM injection on Day 1, Day 57, and Day 169.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type BIOLOGICAL

0.9% sodium chloride (normal saline) injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mRNA-1647

Lyophilized product that is reconstituted with 0.9% sodium chloride (normal saline)

Intervention Type BIOLOGICAL

Placebo

0.9% sodium chloride (normal saline) injection

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants aged ≥20 years, has or anticipates having direct exposure within 7 months after the planned first dose (in the home, socially, or occupationally) to at least 1 child ≤5 years of age. Direct exposure is defined as either participant is the parent, or participant has close contact (feeding, diaper changes, childcare/supervision) for at least 8 hours per week.
* CMV-seronegative Cohort is CMV-seronegative based on CMV testing at Screening.
* CMV-seropositive Cohort is CMV-seropositive based on CMV testing at Screening.
* Investigator assessment confirms that the participant (including in the case of an emancipated minor), or parent(s)/legally acceptable representative (LAR)(s), as applicable, understand and are willing and physically able to comply with protocol-mandated follow-up including all study visits and procedures anticipated during the 30 month study period.
* Female participants of child-bearing potential: Urine pregnancy test is negative at Screening and negative on the day of the first injection (Day 1). If the participant is sexually active with men, has practiced adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection (Day 1) and agrees to continue adequate contraception through 3 months following the third study injection (Month 9/Day 257).

Extension substudy:

* All consenting participants who were CMV-seronegative at Baseline in the mRNA-1647-P301 main study (including those who did seroconvert and did not seroconvert during the main study), received at least one study injection in the main study but did not withdraw study consent, and completed the final study visit in mRNA-1647-P301 main study.
* Consenting participants in mRNA-1647-P301 main study who were CMV-seropositive at Baseline, received all 3 study injections, did not withdraw study consent, and completed the final study visit in the main study.

Exclusion Criteria

* History of a diagnosis or condition that, in the judgment of the Investigator, is clinically unstable or may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures.
* Received or plans to receive any nonstudy vaccine \<28 days prior to and after any study injection; in addition, the following criteria for COVID-19 and influenza vaccines apply:
* Any COVID-19 primary vaccination series must have been completed a minimum 28 days prior to receiving any dose of the study injection.
* COVID-19 vaccines (including any booster dose, regardless of manufacturer) must be administered at least 28 days prior to or after any study injection.
* Influenza vaccines may be administered \> 14 days prior to or after any study injection.
* Received systemic immunosuppressants or immune-modifying drugs for \>14 days in total within 6 months prior to the day of first injection (Day 1) (for corticosteroids, ≥5 milligrams (mg)/day of prednisone equivalent) or plans to do so during the course of the study. Inhaled, nasal, and topical steroids are allowed. Stable immunomodulator regimens used for managing environmental allergies are allowed.
* Receipt of an antiviral with activity against CMV (ganciclovir, valganciclovir, foscarnet, cidofovir, letermovir, acyclovir, valacyclovir) \<2 weeks prior to the day of first injection or plans to do so during the course of the study.
* Previous receipt of an investigational CMV vaccine.
* Receipt of systemic immunoglobulins or blood products \<3 months prior to the day of first injection.
* Participated in an interventional clinical study \<28 days prior to the day of first injection (Day 1) or plans to do so while enrolled in this study.
* Participant has donated ≥450 milliliters (mL) of blood products \<28 days prior to Screening.
* Participant is a member of study team or is an immediate family member or household member of study personnel.

Extension substudy:

* Receipt of any CMV vaccine other than mRNA-1647.
* Diagnosis or condition that, in the judgment of the Investigator, may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures, including any medical, psychiatric, or occupational condition that, in the opinion of the Investigator, might pose additional risk due to participation in the study or could interfere with the interpretation of study results.
Minimum Eligible Age

16 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ModernaTX, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Research Associates Inc

Birmingham, Alabama, United States

Site Status

Accel Research Site - Achieve - Birmingham - ERN - PPDS

Birmingham, Alabama, United States

Site Status

SEC Clinical Research LLC - Dothan - ClinEdge - PPDS

Dothan, Alabama, United States

Site Status

Lakeview Clinical Research

Guntersville, Alabama, United States

Site Status

Chandler Clinical Trials, LLC

Chandler, Arizona, United States

Site Status

Arizona Clinical Trials

Mesa, Arizona, United States

Site Status

Phoenix Clinical LLC

Phoenix, Arizona, United States

Site Status

MedPharmics, LLC

Phoenix, Arizona, United States

Site Status

Hope Research Institute LLC

Phoenix, Arizona, United States

Site Status

Hope Research Institute LLC

Phoenix, Arizona, United States

Site Status

Epic Medical Research Arizona

Surprise, Arizona, United States

Site Status

Voyage Medical

Tempe, Arizona, United States

Site Status

Hope Research Institute LLC

Tempe, Arizona, United States

Site Status

Tucson Neuroscience Research - M3 WR - ERN - PPDS

Tucson, Arizona, United States

Site Status

The Institute for Liver Health-Tucson

Tucson, Arizona, United States

Site Status

Del Sol Research Management - ClinEdge - PPDS

Tucson, Arizona, United States

Site Status

Noble Clinical Research

Tucson, Arizona, United States

Site Status

Baptist Health Center for Clinical Research

Little Rock, Arkansas, United States

Site Status

Preferred Research Partners

Little Rock, Arkansas, United States

Site Status

Applied Research Center of Arkansas - Clinedge - PPDS

Little Rock, Arkansas, United States

Site Status

Velocity Clinical Research - Banning

Banning, California, United States

Site Status

Velocity Clinical Research - Chula Vista

Chula Vista, California, United States

Site Status

Apex Research Group

Fair Oaks, California, United States

Site Status

Ascada Research LLC

Fullerton, California, United States

Site Status

Paradigm Clinical Research Center

La Mesa, California, United States

Site Status

Velocity Clinical Research - San Diego

La Mesa, California, United States

Site Status

Long Beach Research Institute, LLC

Long Beach, California, United States

Site Status

Long Beach Clinical Trials Services Inc.

Long Beach, California, United States

Site Status

Catalina Research Institute LLC

Montclair, California, United States

Site Status

Carbon Health- NoHo West Urgent Care and Primary Care

North Hollywood, California, United States

Site Status

Empire Clinical Research

Pomona, California, United States

Site Status

Paradigm Clinical Research Institute, Inc. - ClinEdge

Redding, California, United States

Site Status

Smart Cures Clinical Research

Rolling Hills Estates, California, United States

Site Status

Northern California Research Corp

Sacramento, California, United States

Site Status

Womens Healthcare Research Corporation ERN PPDS

San Diego, California, United States

Site Status

Care Access Research - Santa Clarita

Santa Clarita, California, United States

Site Status

Stanford University School of Medicine

Stanford, California, United States

Site Status

Clinical Trials Management Services, LLC

Thousand Oaks, California, United States

Site Status

Bayview Research Group

Valley Village, California, United States

Site Status

Next Level Clinical Trials

West Covina, California, United States

Site Status

Care Access Research - Aurora

Aurora, Colorado, United States

Site Status

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

Site Status

Paradigm Clinical Research Institute Inc - ClinEdge

Wheat Ridge, Colorado, United States

Site Status

New England Research Associates LLC - ERN - PPDS

Bridgeport, Connecticut, United States

Site Status

Clinical Research Consultants LLC

Milford, Connecticut, United States

Site Status

Emerson Clinical Research Institute LLC - Kennedy St

Washington D.C., District of Columbia, United States

Site Status

Invictus Clinical Research Group, LLC

Coconut Creek, Florida, United States

Site Status

Luna Research LLC

Coral Gables, Florida, United States

Site Status

Herco Medical and Research Center, Inc.

Coral Gables, Florida, United States

Site Status

Precision Clinical Research, LLC

Coral Springs, Florida, United States

Site Status

Universal Axon Clinical Research

Doral, Florida, United States

Site Status

Unique Clinical Trials, LLC

Doral, Florida, United States

Site Status

Velocity Clinical Research, New Smyrna Beach

Edgewater, Florida, United States

Site Status

Indago Research and Health Center

Hialeah, Florida, United States

Site Status

Best Quality Research, Inc

Hialeah, Florida, United States

Site Status

Florida International Medical Research

Miami, Florida, United States

Site Status

Miami Clinical Research

Miami, Florida, United States

Site Status

Spotlight Research Center, LLC

Miami, Florida, United States

Site Status

Floridian Clinical Research - ClinEdge - PPDS

Miami Lakes, Florida, United States

Site Status

Ormond Beach Clinical Research

Ormond Beach, Florida, United States

Site Status

Emerald Coast OBGYN Clinical Research

Panama City, Florida, United States

Site Status

Ideal Clinical Research, Inc. - ClinEdge - PPDS

Pembroke Pines, Florida, United States

Site Status

Precision Clinical Research - Plantation

Plantation, Florida, United States

Site Status

GCP Global Clinical Professionals

St. Petersburg, Florida, United States

Site Status

Tampa Bay Health Care

Tampa, Florida, United States

Site Status

CVS HealthHub - Atlanta S

Atlanta, Georgia, United States

Site Status

CVS HealthHub - Atlanta

Atlanta, Georgia, United States

Site Status

Tekton Research - Georgia - Platinum

Chamblee, Georgia, United States

Site Status

Centricity Research - Roswel

Columbus, Georgia, United States

Site Status

CVS HealthHub - Dacula

Dacula, Georgia, United States

Site Status

IResearch Atlanta LLC

Decatur, Georgia, United States

Site Status

CVS HealthHub - Kennesaw

Kennesaw, Georgia, United States

Site Status

Drug Studies America - ClinEdge - PPDS

Marietta, Georgia, United States

Site Status

CVS HealthHub - Mcdonough

McDonough, Georgia, United States

Site Status

CVS HealthHub - Newman

Newnan, Georgia, United States

Site Status

One Health Research Clinic, Inc.

Norcross, Georgia, United States

Site Status

Mount Vernon Clinical Research, LLC - M3 WR - ERN - PPDS

Sandy Springs, Georgia, United States

Site Status

CVS HealthHub - Savannah

Savannah, Georgia, United States

Site Status

Clinical Research Prime - Clinedge

Idaho Falls, Idaho, United States

Site Status

Velocity Clinical Research

Meridian, Idaho, United States

Site Status

Affinity Health

Oak Brook, Illinois, United States

Site Status

Optimal Research

Peoria, Illinois, United States

Site Status

ASHA Clinical Research - ClinEdge

Hammond, Indiana, United States

Site Status

Del Pilar Medical and Urgent Care

Mishawaka, Indiana, United States

Site Status

Iowa Clinic

Des Moines, Iowa, United States

Site Status

Johnson Country Clin-Trials

Lenexa, Kansas, United States

Site Status

Alliance for Multispecialty Research, LLC

Newton, Kansas, United States

Site Status

Alliance for Multispecialty Research, LLC

Lexington, Kentucky, United States

Site Status

Velocity Clinical Research - Covington

Metairie, Louisiana, United States

Site Status

Centennial Medical Group - Elkridge - Rx Trials

Elkridge, Maryland, United States

Site Status

Meridian Clinical Research-(Rockville Maryland)

Rockville, Maryland, United States

Site Status

DM Clinical Research - The Brook House

Brookline, Massachusetts, United States

Site Status

Skylight Health Research - Burlington

Burlington, Massachusetts, United States

Site Status

ActivMed Practices & Research Inc

Methuen, Massachusetts, United States

Site Status

Voyage Medical - Michigan

Canton, Michigan, United States

Site Status

Wayne State University

Detroit, Michigan, United States

Site Status

Great Lakes Research Institute

Southfield, Michigan, United States

Site Status

DM Clinical Research - Southfield

Southfield, Michigan, United States

Site Status

Clinical Research Institute, Inc - CRN - PPDS

Minneapolis, Minnesota, United States

Site Status

University of Minnesota Clinical Research Unit

Minneapolis, Minnesota, United States

Site Status

MedPharmics, LLC

Gulfport, Mississippi, United States

Site Status

MediSync Clinical Research Hattiesburg Clinic

Petal, Mississippi, United States

Site Status

Boeson Research GTF - Great Falls

Great Falls, Montana, United States

Site Status

Boeson Research KAL - Kalispell - ERN - PPDS

Kalispell, Montana, United States

Site Status

Boeson Research MSO - Missoula

Missoula, Montana, United States

Site Status

Meridian Clinical Research (Grand Island, Nebraska)

Grand Island, Nebraska, United States

Site Status

Meridian Clinical Research (Hastings, Nebraska)

Hastings, Nebraska, United States

Site Status

Be Well Clinical Studies, LLC - Lincoln - ERN - PPDS

Lincoln, Nebraska, United States

Site Status

Meridian Clinical Research (Norfolk-Nebraska)

Norfolk, Nebraska, United States

Site Status

Quality Clinical Research

Omaha, Nebraska, United States

Site Status

Meridian Clinical Research-(Omaha Nebraska)

Omaha, Nebraska, United States

Site Status

Clinical Research Center Of Nevada

Las Vegas, Nevada, United States

Site Status

Med Clinic Research Partners, LLC

Irvington, New Jersey, United States

Site Status

Albuquerque Clinical Trials Inc.

Albuquerque, New Mexico, United States

Site Status

MedPharmics, LLC. - Albuquerque

Albuquerque, New Mexico, United States

Site Status

Meridian Clinical Research (Endwell-New York) - Platinum - PPDS

Binghamton, New York, United States

Site Status

WellNow Urgent Care Clinical Research

East Amherst, New York, United States

Site Status

Rochester Clinical Research, Inc

Rochester, New York, United States

Site Status

SUNY Upstate Medical Center

Syracuse, New York, United States

Site Status

OnSite Clinical Solutions, LLC

Charlotte, North Carolina, United States

Site Status

Carolina Institute for Clinical Research - M3 WR - ERN - PPDS

Fayetteville, North Carolina, United States

Site Status

Monroe Biomedical Research (Venus St)

Monroe, North Carolina, United States

Site Status

Lucas Research

Morehead City, North Carolina, United States

Site Status

M3 Wake Research, Inc - M3 WR - ERN - PPDS

Raleigh, North Carolina, United States

Site Status

Lillestol Research

Fargo, North Dakota, United States

Site Status

CTI Clinical Research Center - ClinEdge - PPDS

Cincinnati, Ohio, United States

Site Status

Meridian Cincinnati

Cincinnati, Ohio, United States

Site Status

University of Cincinnati Medical Center-Goodman St

Cincinnati, Ohio, United States

Site Status

ClinOhio Research Services

Columbus, Ohio, United States

Site Status

Aventiv Research Inc.

Columbus, Ohio, United States

Site Status

WellNow Urgent Care & Research - Huber Heights

Columbus, Ohio, United States

Site Status

PriMed Clinical Research - ClinEdge

Dayton, Ohio, United States

Site Status

Senders Pediatrics

South Euclid, Ohio, United States

Site Status

Epic Medical Research Oklahoma

Chickasha, Oklahoma, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Tekton Research - Oklahoma - Platinum

Yukon, Oklahoma, United States

Site Status

Velocity Clinical Research - Medford

Medford, Oregon, United States

Site Status

SPICA Clinical Research

Columbia, South Carolina, United States

Site Status

PMG Research of Charleston LLC

Mt. Pleasant, South Carolina, United States

Site Status

Coastal Carolina Research Center

North Charleston, South Carolina, United States

Site Status

ARC Clinical Research at Wilson Parke

Austin, Texas, United States

Site Status

Premier Family Physicians - Austin - Hunt

Austin, Texas, United States

Site Status

ARC Clinical Research at William Cannon

Austin, Texas, United States

Site Status

Tekton Research, Inc.

Austin, Texas, United States

Site Status

Gadolin Research LLC

Beaumont, Texas, United States

Site Status

REX Clinical Trials

Beaumont, Texas, United States

Site Status

Tekton Research - Beaumont

Beaumont, Texas, United States

Site Status

Velocity Clinical Research - Austin

Cedar Park, Texas, United States

Site Status

Global Medical Research

Dallas, Texas, United States

Site Status

Zenos Clinical Research

Dallas, Texas, United States

Site Status

ANRC Research

El Paso, Texas, United States

Site Status

Village Health Partners Frisco Medical Village

Frisco, Texas, United States

Site Status

Trio Clinical Trials LLC

Houston, Texas, United States

Site Status

Vilo Research Group, L.L.C.

Houston, Texas, United States

Site Status

New Horizon Medical Group, LLC

Houston, Texas, United States

Site Status

Cedar Health Research - Fort Worth - PPDS

Irving, Texas, United States

Site Status

Helios CCR, Inc.-keller-PPDS

Keller, Texas, United States

Site Status

University of Texas Medical Branch - Bay Colony, SIVS Clinical Trials Program

League City, Texas, United States

Site Status

BRCR Medical Center Inc - McAllen

McAllen, Texas, United States

Site Status

Synergy Group US, LLC

Missouri City, Texas, United States

Site Status

Austin Regional Clinic ARC Clinical Research at Kelly Lane

Pflugerville, Texas, United States

Site Status

GLRI McAllen Research

Pharr, Texas, United States

Site Status

ACRC Trials - Independence Parkway - Plano - Hunt - PPDS

Plano, Texas, United States

Site Status

Epic Medical Research LLC

Red Oak, Texas, United States

Site Status

Clinical Trials of Texas, Inc. - HyperCor

San Antonio, Texas, United States

Site Status

Diagnostics Research Group

San Antonio, Texas, United States

Site Status

DM Clinical Research

Tomball, Texas, United States

Site Status

Crossroads Clinical Research (Victoria)

Victoria, Texas, United States

Site Status

ClinPoint Trials LLC

Waxahachie, Texas, United States

Site Status

Tanner Clinic

Layton, Utah, United States

Site Status

Granger Medical Clinic - Riverton

Riverton, Utah, United States

Site Status

Foothill Family Clinic

Salt Lake City, Utah, United States

Site Status

Foothill Family Clinic - South Clinic

Salt Lake City, Utah, United States

Site Status

Velocity Clinical Research

West Jordan, Utah, United States

Site Status

Health Research of Hampton Roads Inc. - ClinEdge

Newport News, Virginia, United States

Site Status

York Clinical Research

Norfolk, Virginia, United States

Site Status

David Ramstad Associates Research - IACT - HyperCore - PPDS

Suffolk, Virginia, United States

Site Status

Rainier Clinical Research Center

Renton, Washington, United States

Site Status

Seattle Clinical Research Center

Seattle, Washington, United States

Site Status

Velocity Clinical Research - Spokane - PPDS

Spokane, Washington, United States

Site Status

University Of Wisconsin - Madison

Madison, Wisconsin, United States

Site Status

Paratus Clinical Research

Bruce, Australian Capital Territory, Australia

Site Status

Paratus Clinical Research - Western Sydney

Blacktown, New South Wales, Australia

Site Status

Northern Beaches Clinical Research

Brookvale, New South Wales, Australia

Site Status

Northside Health

Coffs Harbour, New South Wales, Australia

Site Status

Kanwal Medical Complex

Kanwal, New South Wales, Australia

Site Status

Hunter Diabetes Centre

Merewether, New South Wales, Australia

Site Status

Emeritus Research

Botany, North South Wales, Australia

Site Status

University of the Sunshine Coast, Health Hub Morayfield

Morayfield, Queensland, Australia

Site Status

University of the Sunshine Coast

Sippy Downs, Queensland, Australia

Site Status

USC Southbank

Southbank, Queensland, Australia

Site Status

Emeritus Research

Camberwell, Victoria, Australia

Site Status

Barwon Health

Geelong, Victoria, Australia

Site Status

The University of Melbourne

Melbourne, Victoria, Australia

Site Status

Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Telethon Kids Institute

Nedlands, Western Australia, Australia

Site Status

Center for Vaccinology (CEVAC)

Ghent, Oost-Vlaanderen, Belgium

Site Status

AZ Sint-Lucas Brugge

Bruges, West-Vlaanderen, Belgium

Site Status

CHU de Liège

Liège, , Belgium

Site Status

University of Alberta Hospital

Edmonton, Alberta, Canada

Site Status

Canadian Center for Vaccinology

Halifax, Nova Scotia, Canada

Site Status

LMC Manna Research - Burlington - HyperCore - PPDS

Burlington, Ontario, Canada

Site Status

Ottawa Hospital

Ottawa, Ontario, Canada

Site Status

Bluewater Clinical Research Group

Sarnia, Ontario, Canada

Site Status

Dr. Anil K. Gupta Medicine Professional Corporation

Toronto, Ontario, Canada

Site Status

Centricity Research - Toronto

Toronto, Ontario, Canada

Site Status

Centricity Research - Quebec - HyperCore - PPDS

Lévis, Quebec, Canada

Site Status

Centricity Research - Mirabel - HyperCore - PPDS

Mirabel, Quebec, Canada

Site Status

McGill University Health Center

Montreal, Quebec, Canada

Site Status

McGill University Health Centre-Vaccine Study Centre

Pierrefonds, Quebec, Canada

Site Status

Centricity Research - Montreal - HyperCore - PPDS

Pointe-Claire, Quebec, Canada

Site Status

Diex Recherche - Québec - HyperCore

Québec, Quebec, Canada

Site Status

Diex Recherche - Joilette - HyperCore - PPDS

Saint-Charles-Borromée, Quebec, Canada

Site Status

Diex Recherche - Sherbrooke - HyperCore

Sherbrooke, Quebec, Canada

Site Status

Diex Recherche - Victoriaville - HyperCore

Victoriaville, Quebec, Canada

Site Status

CCBR Clinical Research

Tallinn, Harju, Estonia

Site Status

Al Mare Family Doctors Centre

Tallinn, Harju, Estonia

Site Status

Merelahe Family Doctors Centre

Tallinn, Harju, Estonia

Site Status

Vee Family Doctors Center Ltd

Paide, Järvamaa, Estonia

Site Status

Clinical Research Centre Ltd.

Tartu, Tartu, Estonia

Site Status

Etelä Helsingin Rokotetutkimusklinikka

Helsinki, Etelä-Suomen Lään, Finland

Site Status

Kokkolan Rokotetutkimusklinikka

Kokkola, Keski-Pohjanmaa, Finland

Site Status

Oulun Rokotetutkimusklinikka

Oulu, Oulun Lääni, Finland

Site Status

Tampereen Rokotetutkimusklinikka

Tampere, Pirkanmaa, Finland

Site Status

Porin Rokotetutkimusklinikka

Pori, Satakunta, Finland

Site Status

Tampereen Yliopisto Seinajoen Rokotusklinikka

Seinäjoki, South Ostrobothnia, Finland

Site Status

Espoon rokotetutkimusklinikka

Espoo, Uusimaa, Finland

Site Status

Itä Helsingin Rokotetutkimusklinikka

Helsinki, Uusimaa, Finland

Site Status

Järvenpään Rokotetutkimusklinikka

Järvenpää, Uusimaa, Finland

Site Status

Turun Rokotetutkimusklinikka

Turku, Västra Finlands Län, Finland

Site Status

CHRU Nantes

Nantes, Pays de la Loire Region, France

Site Status

Centre Hospitalier Departemental de Vendee

La Roche-sur-Yon, , France

Site Status

Centre Hospitalier et Universitaire de Limoges

Limoges, , France

Site Status

CHU Montpellier - Hôpital St Eloi

Montpellier, , France

Site Status

Hopital Necker

Paris, , France

Site Status

Groupe Hospitalier Cochin Saint Vincent de Paul

Paris, , France

Site Status

Centre Hospitalier Lyon Sud

Pierre-Bénite, , France

Site Status

Centre Hospitalier Universitaire de Saint Etienne

Saint-Priest-en-Jarez, , France

Site Status

CHRU de Tours

Tours, , France

Site Status

TriDerm

Stuttgart, Baden-Wurttemberg, Germany

Site Status

Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, Germany

Site Status

Frauenarztpraxis Erwin Göckeler-Leopold

Geseke, North Rhine-Westphalia, Germany

Site Status

Dermatologie Quist

Mainz, Rhineland-Palatinate, Germany

Site Status

Klifeck GmbH

Delitzsch, Saxony, Germany

Site Status

RED-Institut GmbH

Oldenburg in Holstein, Schleswig-Holstein, Germany

Site Status

Praxis Reinfeld-Mitte

Reinfeld, Schleswig-Holstein, Germany

Site Status

Berliner Centrum für Reise- und Tropenmedizin BCRT GmbH

Berlin, , Germany

Site Status

Bernhard Nocht Centre for Clinical Trials (BNCCT)am Bernhard-Nocht-Institut für Tropenmedizin

Hamburg, , Germany

Site Status

Velocity Clinical Research - Hamburg - PPDS

Hamburg, , Germany

Site Status

Office of Klaus H. Peters, Dr.med

Hamburg, , Germany

Site Status

Velocity Clniical Research Leipzip Gmbh

Leipzig, , Germany

Site Status

AmBeNet GmbH

Leipzig, , Germany

Site Status

Centrum Für Diagnostik und Gesundheit

München, , Germany

Site Status

Medislim GmbH - Zentrum fuer Ambulante Klinische Forschung

Weinheim, , Germany

Site Status

Sheba Medical Center - PPDS

Petah Tikva, Central District of Israel, Israel

Site Status

Rambam Medical Center - PPDS

Haifa, Haifa Hefa, Israel

Site Status

Shamir Medical Center Assaf Harofeh

Beer Yaakov, Rishon Lezion, Israel

Site Status

Soroka University Medical Centre

Beer Sheva, Tel Aviv, Israel

Site Status

Maccabi Hashalom

Tel Aviv, Tel Aviv, Israel

Site Status

Hadassah Medical Center - PPDS

Jerusalem, Yerushalayim Al Quds, Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, Yerushalayim Al Quds, Israel

Site Status

Meir Medical Center

Kfar Saba, , Israel

Site Status

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Tel Aviv Sourasky Medical Center PPDS

Tel Aviv, , Israel

Site Status

Ospedale Policlinico San Martino

Genova, , Italy

Site Status

Fondazione IRCCS San Gerardo dei Tintori - MBBM - c/o Centro Maria Letizia Verga

Monza, , Italy

Site Status

Clinical Trial Site

Funabashi-shi, Chiba, Japan

Site Status

Clinical trial site

Fukuoka, Fukuoka, Japan

Site Status

Clinical Trial Site

Sapporo, Hokkaido, Japan

Site Status

Clinical Trial Site

Sapporo, Hokkaido, Japan

Site Status

Kobe University Hospital

Kobe, Hyôgo, Japan

Site Status

Clinical trial site

Osaka-shi Osaka, Kansai, Japan

Site Status

Clinical Trial Site

Habikino-shi, Osaka, Japan

Site Status

Clinical Trial Site

Osaka, Osaka, Japan

Site Status

Clinical Trial Site

Sakai-shi, Osaka, Japan

Site Status

Clinical Trial Site

Kawagoe-shi, Saitama, Japan

Site Status

Clinical Trial Site

Chuo-ku, Tokyo, Japan

Site Status

Clinical Trial Site

Chuo-ku, Tokyo, Japan

Site Status

Clinical Trial Site

Shibuya-ku, Tokyo, Japan

Site Status

Clinical Trial Site

Shinjuku, Tokyo, Japan

Site Status

Clinical Trial Site

Taito-ku, Tokyo, Japan

Site Status

C.H. Regional Reina Sofia

Córdoba, Andalusia, Spain

Site Status

Hospital Quironsalud Malaga

Málaga, Andalusia, Spain

Site Status

Instituto Hispalense de Pediatria

Seville, Andalusia, Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, Catalonia, Spain

Site Status

ABS Centelles

Centelles, Catalonia, Spain

Site Status

CHUS - H. Clinico U. de Santiago

Santiago de Compostela, Galicia, Spain

Site Status

Hospital HM Puerta del Sur

Móstoles, Madrird, Spain

Site Status

Hospital Universitario La Paz.

Madrid, , Spain

Site Status

The James Cook University Hospital

Middlesbrough, Cleveland, United Kingdom

Site Status

William Harvey Clinical Research Centre

London, England, United Kingdom

Site Status

St George s Vaccine Institute

London, England, United Kingdom

Site Status

Lakeside Surgery

Corby, Northamptonshire, United Kingdom

Site Status

NIHR Patient Recruitment Centre: Newcastle

Newcastle upon Tyne, Northumberland, United Kingdom

Site Status

St Michaels Hospital

Bristol, South West England, United Kingdom

Site Status

NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Canada Estonia Finland France Germany Israel Italy Japan Spain United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Galiza EP, Khalil A, Heath PT. Update on Vaccines in Antenatal Care. Pediatr Infect Dis J. 2024 Feb 1;43(2):e60-e62. doi: 10.1097/INF.0000000000004183. Epub 2023 Dec 27. No abstract available.

Reference Type DERIVED
PMID: 38190492 (View on PubMed)

Stewart AG, Kotton CN. What's New: Updates on Cytomegalovirus in Solid Organ Transplantation. Transplantation. 2024 Apr 1;108(4):884-897. doi: 10.1097/TP.0000000000004855. Epub 2023 Oct 30.

Reference Type DERIVED
PMID: 37899366 (View on PubMed)

Kadambari S, Evans C, Lyall H. Congenital Infections: Priorities and Possibilities for Resource-limited Settings. Pediatr Infect Dis J. 2023 Feb 1;42(2):e45-e47. doi: 10.1097/INF.0000000000003710. Epub 2022 Sep 12. No abstract available.

Reference Type DERIVED
PMID: 36102707 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-006051-17

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

2023-508820-37-00

Identifier Type: OTHER

Identifier Source: secondary_id

mRNA-1647-P301

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.